R&D
Technology to Increase Selectivity for
cancer cells and Enhance Efficacy
Business Performance
  • HOME
  • R&D
  • Business Performance
PINOT-ADC™
  • Aptamer sciences
    2022.10

    ADCs Joint Research,
    and Strategic Investment

  • aptamer group
    2022.08

    KDDF Governmental Study developing new drugs
    Jointly Won(ProEn Therapeutics Co., Ltd.)

  • proen
    2021.05

    Aptamer-Drug Conjugates
    Additional Joint Research

  • proen
    2022.02

    ADCs Joint Research

  • proen
    2021.07

    Aptamer-Drug Conjugates
    Joint Research

  • proen
    2021.06

    Aptamer-Drug Conjugates
    Joint Research

  • proen
    2021.06

    Repebody-Drug Conjugates
    Joint Research

NTX-301
  • aston sci
    2021.03

    CMC development cooperation,
    Strategic Investment